Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

SAT0479 Clinical impact of immunogenicity of infliximab, adalimumab and etanercept: A systematic review of the literature with a meta-analysis

(2014) S. Garcês et al.   ANNALS OF THE RHEUMATIC DISEASES

Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System

(2013) P. Deepak et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

(2013) John W Baddley et al.   ANNALS OF THE RHEUMATIC DISEASES

A systematic review of the evidence for the treatment of acute depression in bipolar I disorder

(2013) Michael A. Cerullo et al.   CNS SPECTRUMS

Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: A systematic review

(2013) Arun V. Ravindran et al.   JOURNAL OF AFFECTIVE DISORDERS

Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2

(2013) Manola Comar et al.   JOURNAL OF MEDICAL VIROLOGY

EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials

(2013) Julian G Martins   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial

(2013) Theodore M. Brasky et al.   JNCI-Journal of the National Cancer Institute

Early interventions to prevent psychosis: systematic review and meta-analysis

(2013) M. R. Stafford et al.   BMJ-British Medical Journal

Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study

(2012) Patience J. Gallagher et al.   AMERICAN JOURNAL OF PSYCHIATRY

Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration

(2012) Lucile Capuron et al.   ARCHIVES OF GENERAL PSYCHIATRY

Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial

(2012) Janice K. Kiecolt-Glaser et al.   BRAIN BEHAVIOR AND IMMUNITY

Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders

(2012) R. M. Ortega et al.   BRITISH JOURNAL OF NUTRITION

Minocycline

(2012) Olivia M. Dean et al.   CNS DRUGS

Can bipolar disorder be viewed as a multi-system inflammatory disease?

(2012) Marion Leboyer et al.   JOURNAL OF AFFECTIVE DISORDERS

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

(2012) Seyed-Hesameddin Abbasi et al.   JOURNAL OF AFFECTIVE DISORDERS

Eicosapentaenoic Acid Interventions in Schizophrenia

(2012) Paolo Fusar-Poli et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis

(2012) J G Martins et al.   MOLECULAR PSYCHIATRY

Association between anti-TNF-α therapy and all-cause mortality

(2012) Lisa J. Herrinton et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis

(2012) Andrea L. Jorgensen et al.   PLoS One

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study

(2012) Tsuyoshi Miyaoka et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies

(2012) Brian J. Miller et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

(N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders

(2012) Pedro Luis Prior et al.   Advances in Nutrition

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

(2012) Jonathan Savitz et al.   BMJ Open

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

(2012) N Vogelzangs et al.   Translational Psychiatry

Relation Between Red Blood Cell Omega-3 Fatty Acid Index and Bleeding During Acute Myocardial Infarction

(2011) Adam C. Salisbury et al.   AMERICAN JOURNAL OF CARDIOLOGY

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

(2011) Brian J. Miller et al.   BIOLOGICAL PSYCHIATRY

Fish consumption and the risk of gastric cancer: systematic review and meta-analysis

(2011) Shengjun Wu et al.   BMC CANCER

Cause for concern in the use of non-steroidal anti-inflammatory medications in the community -a population-based study

(2011) Robert J Adams et al.   BMC Family Practice

Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial

(2011) Janice K. Kiecolt-Glaser et al.   BRAIN BEHAVIOR AND IMMUNITY

Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review

(2011) Apostolos Iacovides et al.   CURRENT OPINION IN PSYCHIATRY

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells

(2011) Sigalit Nahman et al.   Innate Immunity

An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces

(2011) Roosmarijn C. Drexhage et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression

(2011) Yang Liu et al.   JOURNAL OF AFFECTIVE DISORDERS

Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia

(2011) Iris E. Sommer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 for Bipolar Disorder

(2011) Jerome Sarris et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 and Fish Oil Supplements Do Not Cause Increased Bleeding During Spinal Decompression Surgery

(2011) Christopher K. Kepler et al.   JOURNAL OF SPINAL DISORDERS & TECHNIQUES

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens

(2011) R. Gniadecki et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Multiple sclerosis and depression

(2011) Anthony Feinstein   Multiple Sclerosis Journal

Grand challenges in global mental health

(2011) Pamela Y. Collins et al.   NATURE

Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review

(2011) Juan Undurraga et al.   NEUROPSYCHOPHARMACOLOGY

Astrocytic Hypertrophy in Anterior Cingulate White Matter of Depressed Suicides

(2011) Susana G Torres-Platas et al.   NEUROPSYCHOPHARMACOLOGY

The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

(2011) Jonas Hannestad et al.   NEUROPSYCHOPHARMACOLOGY

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

(2011) Brian Leonard et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Omega-3 fatty acid deficiency: A preventable risk factor for schizophrenia?

(2011) Robert K. McNamara   SCHIZOPHRENIA RESEARCH

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation

(2011) Michele Fornaro et al.   Neuropsychiatric Disease and Treatment

Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed mood

(2010) Katherine M Appleton et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Effets secondaires des biothérapies chez l’enfant

(2010) B. Bader-Meunier   ARCHIVES DE PEDIATRIE

Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward

(2010) Naomi I. Eisenberger et al.   BIOLOGICAL PSYCHIATRY

Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder

(2010) Barbara L Gracious et al.   BIPOLAR DISORDERS

Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder

(2010) Robin E Duncan et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

(2010) Debbie G. A. Janssen et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls

(2010) Léia CR Silva et al.   Immunotherapy

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders

(2010) Wijnand Laan et al.   JOURNAL OF CLINICAL PSYCHIATRY

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

(2010) M. Berk et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia

(2010) M.M. Sethom et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

TNF-  antagonists beyond approved indications: stories of success and prospects for the future

(2010) M. P. Karampetsou et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

(2010) Norbert Müller et al.   SCHIZOPHRENIA RESEARCH

Mood-Stabilizers Target the Brain Arachidonic Acid Cascade

(2010) Jagadeesh Rao et al.   Current Molecular Pharmacology

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

(2009) J Kekow et al.   ANNALS OF THE RHEUMATIC DISEASES

Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model

(2009) Tien-Yu Huang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?

(2009) Richard P. Bazinet   BIOCHEMICAL SOCIETY TRANSACTIONS

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice

(2009) Shadi Homsi et al.   BRAIN RESEARCH

Bipolar disorder and mechanisms of action of mood stabilizers

(2009) Stanley I. Rapoport et al.   BRAIN RESEARCH REVIEWS

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

(2009) Shahin Akhondzadeh et al.   DEPRESSION AND ANXIETY

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

(2009) Roosmarijn C Drexhage et al.   Expert Review of Neurotherapeutics

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder

(2009) Benjamin I. Goldstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia

(2009) Yechiel Levkovitz et al.   JOURNAL OF CLINICAL PSYCHIATRY

Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update

(2009) Ann Corken Mackey et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat

(2009) Beom Joon Kim et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression?

(2009) Joanna K. Soczynska et al.   NEUROTOXICOLOGY

Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder

(2009) Pieter Stolk et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research

(2009) Sang-Ho Choi et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis

(2008) S.R. Feldman et al.   BRITISH JOURNAL OF DERMATOLOGY

Minocycline as Adjunctive Therapy for Schizophrenia

(2008) Tsuyoshi Miyaoka et al.   CLINICAL NEUROPHARMACOLOGY

Clinical Potential of Minocycline for Schizophrenia

(2008) Tsuyoshi Miyaoka   CNS & Neurological Disorders-Drug Targets

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study

(2008) Fabiano G. Nery et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor

(2008) Hongwei Yang et al.   JOURNAL OF NEUROCHEMISTRY

Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2

(2008) Saba Aid et al.   Journal of Neuroinflammation

Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?

(2008) J S Rao et al.   MOLECULAR PSYCHIATRY

Are some cases of psychosis caused by microbial agents? A review of the evidence

(2008) R H Yolken et al.   MOLECULAR PSYCHIATRY

NMDA-induced seizure intensity is enhanced in COX-2 deficient mice

(2008) Christopher D. Toscano et al.   NEUROTOXICOLOGY

Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats

(2008) Miguel Molina-Hernández et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease

(2008) Stanley I. Rapoport   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia

(2008) U. Meyer et al.   SCHIZOPHRENIA BULLETIN

Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab

(2008) A. J. Tookman et al.   SUPPORTIVE CARE IN CANCER

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

(2007) Stéphane Potvin et al.   BIOLOGICAL PSYCHIATRY

Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury

(2007) Sang-Ho Choi et al.   FASEB JOURNAL

From inflammation to sickness and depression: when the immune system subjugates the brain

(2007) Robert Dantzer et al.   NATURE REVIEWS NEUROSCIENCE

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS

Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity

(2007) Manuj Ahuja et al.   TOXICOLOGY

Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide

(2006) Johann Steiner et al.   JOURNAL OF PSYCHIATRIC RESEARCH